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For centuries, tuberculosis, which is a chronic infection caused by the bacillus Mycobacterium 
tuberculosis has remained a global health problem. The global burden of tuberculosis has 
increased, particularly in the Southern African region, mainly due to HIV, and inadequate health 
systems which has in turn given rise to emergent drug resistant tuberculosis (TB) strains. Bovine 
tuberculosis (BTB) has also emerged as a significant disease with the tendency for inter-species 
spread. The extent of interspecies BTB transmission both in urban and rural communities has not 
been adequately assessed. The phenomenon is of particular importance in rural communities 
where people share habitats with livestock and wildlife (particularly in areas near national parks 
and game reserves). Aerosol and oral intake are the major routes of transmission from diseased 
to healthy individuals, with health care workers often contracting infection nosocomially. 
Although TB control has increasingly been achieved in high-income countries, the disease, like 
other poverty-related infections, has continued to be a disaster in countries with low income 
economies. Transmission of infections occurs not only amongst humans but also between 
animals and humans (and occasionally vice versa) necessitating assessment of the extent of 
transmission at their interface. This review explores tuberculosis as a disease of humans which 
can cross-transmit between humans, livestock and wildlife. The review also addresses issues 
underlying the use of molecular biology, genetic sequencing and bioinformatics as t tools to 
understand the extent of inter-species cross-transmission of TB in a ‘One Health’ context. 
© 2012. The Authors. Licensee: AOSIS OpenJournals. This work is licensed under the Creative Commons Attribution License.
Introduction
Humans and animals have had close interactions as long as we have historical knowledge of 
man. This interaction largely contributes to the evolution and ongoing transmission of shared 
infectious diseases. The need for a systematic global effort to monitor for emerging human is 
important since most major human infectious diseases are thought to have animal origins (Wolfe, 
Dunavan & Diamond 2007), examples being helminths, tuberculosis (TB), brucellosis, foot-and-
mouth disease, leptospirosis, anthrax and Rift Valley fever (RVF). Studies on 1415 pathogenic 
diseases in human and animals (Cleaveland, Laurenson & Taylor 2001) have revealed 61.6% as 
multi-host pathogens, suggesting the need for monitoring these important infectious diseases. 
Available data indicate that more than 80% of human and cattle populations of Africa live in an 
area with partial or no control of bovine TB (Cosivi et al. 1998; WHO/DFID 2006; WHO 2004). 
There is ample evidence that such lack of control and close contact of the two species contributes 
to TB transmission, mostly Mycobacterium bovis from cattle to humans. Perhaps the best-studied 
example and illustration of the effectiveness of control measures was the situation in Western 
Europe (Germany as a good example) prior to the 1950s, where M. bovis infection in cattle was 
common, and M. bovis was present in perhaps 15% of human cases. After strict control measures 
were introduced, M. bovis prevalence dropped effectively to zero in both species, with only the 
occasional reactivation case seen in the elderly, or in new immigrants coming from areas where 
M. bovis is not controlled. The extent of M. bovis infection and disease is not properly known in 
almost every environment. Many tests, for example, tuberculin skin test (TST) and assays based on 
gamma interferon response may indicate exposure, but neither indicates disease nor an indication 
of whether infection is from Mycobacterium tuberculosis, M. bovis, or possibly other mycobacteria, 
particularly those of the M. tuberculosis complex. The usual assumption is that if the test is done 
in a bovid, then the presence of or exposure to M. bovis is indicated, whereas if done in humans, 
then M. tuberculosis is indicated. However, this may not be true, since cross–reactivity does occur. 
At this stage, the gold standard for identification remains microbiological, whether culture or 
done by molecular techniques. Tuberculosis can present in many ways, and in humans, a frequent 
manifestation of bovine TB is extra-pulmonary tuberculosis (EPTB). Unfortunately, M. tuberculosis 
can also present in extra-pulmonary form, although less frequently. Extra-pulmonary tuberculosis 
driven by M. tuberculosis can also occur more frequently in children and individuals who are 
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immunocompromised, for example, HIV positive (Connolly 
et al. 2004; Heymann 2011). Therefore, although EPTB can 
be used as an indicator (or rather, index of suspicion) of 
M. bovis infection in humans, this should only be considered 
seriously in areas or individuals where exposure to bovine 
TB is likely or suspected. Nevertheless, EPTB prevalence can 
be used as an indicator of M. bovis in humans. The control of 
this disease clearly requires significant efforts on the part of 
both veterinary and human health care practitioners and this 
article will address this cross-species issue in particular.
Transmission at the human-
livestock-wildlife interface
Transmission of bovine tuberculosis from animals to humans 
can occur most likely via aerosol exposure or through 
consumption of un-pasteurised milk and other affected 
animal products. Reports from Tanzania covering the period 
from 2008 to 2009 suggest that EPTB accounted for over 20% 
of the cases of TB and showed a marginal annual increment 
(National TB Control Program Report 2011, in preparation). 
This high level prevalence of EPTB plus other data (Cook 
et al. 1996) suggests the presence of mycobacteria other than 
M. tuberculosis occur extensively in the Tanzanian population. 
We note that more extra-pulmonary cases are contributed 
by M. tuberculosis than M. bovis by total case load; however, 
such a high prevalence rate is unlikely to be due entirely to 
M. tuberculosis. A study by Cook et al. (1996) in Monze District 
of Zambia, reported for cattle in larger herds, in households 
with previously report of human tuberculosis cases (preceding 
12 months) to be more likely tuberculin test positive (six 
times) than those without previous reported human TB case. 
This could reflect TB cross-transmission between species. In 
the same year, a variety of different mycobacteria, including 
M. tuberculosis, were isolated from dairy cattle and milk in 
Tanzania (Kazwala et al. 1998). Studies in the Netherlands 
(Majoor et al. 2011) indicate mainly (58.9%) extra-pulmonary 
M. bovis infection in humans. Although individuals may 
develop the pulmonary form of M. bovis disease, person-
to-person transmission is said to be unlikely, based on data 
from genotype analysis (Majoor et al. 2011). There are reports 
on elephant-to-human transmission of tuberculosis due to 
indirect exposure to aerosolised M. tuberculosis (Murphree 
et al. 2011). The infection has been exacerbated by delayed 
or inadequate disease control practices. Other reports have 
indicated M. tuberculosis as an emerging disease in Asian 
elephants in zoological collections (Mikota et al. 2001). 
Finally, there are unpublished reports that M. tuberculosis has 
been detected in a number of Ethiopian cattle, transferred 
from the human owners directly to the animals (Paul van 
Helden from D Young pers. comm., n.d.). 
The implication, impact and challenges underlying zoonotic 
tuberculosis to both humans and animals has been repeatedly 
emphasised (Cataldi & Romano 2007; Cleaveland et al. 2005; 
Kazwala et al. 1998, 2001a; Michel 2002b; Michel et al. 2006; 
Michel, Müller & Van Helden 2010; Woodroffe et al. 2009). Yet 
diagnosis by acid fast smear is still widely used and often the 
only non-clinical diagnostic since it is affordable. But this test, 
despite being the keystone of tuberculosis diagnosis in Africa, 
does not permit differentiation between M. tuberculosis 
and M. bovis, or any other mycobacterial species. Thus, it is 
essential that better diagnostics are applied in order that we 
may know the extent and nature of the problem at hand. In 
addition, the conventional means of control are difficulty to 
apply once the infection enters into wildlife species which 
are common maintenance hosts in most cases (Michel 2002a; 
Palmer 2007). Animals are regarded to be the main source 
of zoonotic tuberculosis infection in humans. However, as 
outlined above, reports also indicate that humans are not 
the only victims from cross-species infection by tuberculosis, 
but are also potential sources of infection, even to free-living 
wildlife at their interface (Alexander et al. 2002). This creates 
room for researchers to look at the disease from both sides 
of the coin. Aerosol and oral transmission are the major 
routes of transmission in patients, with health care workers 
contracting infection nosocomially. In wildlife, similar 
routes are proposed with carnivores and omnivores said 
to contract infections via scavenging of bovine tuberculosis 
infected carcasses and killing and consumption of infected 
prey such as antelope or wild bovids (Michel et al. 2006). 
This is evident from proven bovine tuberculosis in predators 
(Keet et al. 2001). 
Intensification of animal-human contact enhances the 
likelihood of cross-over and an increased risk of transmission 
for both M. tuberculosis as well as M. bovis at the interface. 
Cross-transmission in infectious disease is not a newly 
emerging view but linked to the co-evolution of humans, 
the animals with which they co-exist and evolve and the 
microorganisms in their environment (Diamond 2002; Wirth 
et al. 2008). Once a pathogen has crossed over into a new 
species of host, for example from animal to human, it may 
transform into a specialised pathogen of humans Wolfe 
et al. (2007).
A number of studies have been done reflecting the impact 
bovine tuberculosis may pose to wildlife (Alexander 
et al. 2002; Cleaveland et al. 2005; De Garine-Wichatitsky 
et al. 2010; Michel et al. 2006, 2007). Others have focused on 
livestock alone (Aranaz et al. 2003; Cousins 2001; Durnez 
et al. 2009, 2011; Shirima, Kazwala & Kambarage 2003; 
Kazwala et al., 2001b) and others in humans alone (Kazwala 
et al. 1998; Mfinanga et al. 2004; Ngowi et al. 2008), mostly 
using conventional diagnostic and evaluation means of the 
disease. A review published recently (Michel et al. 2010) 
pinpointed bovine tuberculosis in particular, to be a disease 
of low-income countries with a multifaceted impact affecting 
the health of livestock, humans and the ecosystems. In the 
same review, it is also speculated that the disease is likely to 
increase in situations where HIV and AIDS occurs. 
Recent work has characterised M. bovis isolates and reported 
that regional clonal complexes predominating in specific 
areas occur, for example Af1 M. bovis complex in west-
central Africa (Muller et al. 2009), Af2 prevalent in East Africa 
(Berg et al. 2011) as well as European 1 with European origin 
(Smith et al. 2011). Thus we do not yet know for certain whether 
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M. bovis is an endemic or alien disease to Africa, or whether 
it is endemic to some areas (e.g. some parts of West and East 
Africa) but alien to others. Certainly, there is no evidence to 
suggest that any form of M. bovis is endemic or indigenous to 
South Africa. Better unpacking of this information is needed, 
since it may impact on how we view this disease and respond 
to it. We do not know the relative frequency of the African 
and European type M. bovis in any area and it may be that the 
European variety dominates as an alien invasive organism. It 
may be that indigenous African cattle and wildlife in some 
areas are relatively resistant to bovine TB, which we may 
take advantage of in our responses to the disease. 
Several studies and reviews surveying the zoonotic TB status 
in animals and humans have been published (Cataldi & 
Romano 2007). Different study designs, methods of analysis 
and various study-dependent objectives largely influence the 
outcome and interpretation of these studies. Differences in 
outcomes amongst these different studies nevertheless reflect 
the diversity of disease dynamics in different communities 
and methodological shortcomings have been revealed 
(Heldal et al. 2003; Murray & Alland 2002). 
A new concern is that cross-species transmission may 
play a role in emergent drug resistant tuberculosis. 
Mycobacterium bovis is inherently resistant to pyrazinamide, 
one of the four first line antibiotics, and thus inadequate and/
or inappropriate treatment of apparent M. tuberculosis in a 
human can easily result in acquisition of further resistance in 
M. bovis. Drug-resistant M. bovis in human disease has already 
been reported in a number of countries (Blazquez et al. 1997; 
Hughes et al. 2003; Sechi et al. 2001). This is essentially risky 
for African populations due to a close association of TB with 
HIV and often poor patient adherence and problems with 
implementing a good DOTS programme as advocated by 
Word Health Organisation (WHO). Likewise, transmission 
of drug resistant M. tuberculosis to animals and back to 
humans is not impossible, although likely to be very rare. In 
rural communities, milk pasteurisation is not common and 
M. bovis survival in cow’s milk is effective. Therefore, despite 
reports that humans are less susceptible to bovine TB than 
M. tuberculosis (De la Rua-Domenech 2006) we cannot ignore 
these known problems and complications. 
Possible contributing factors to 
increased transmission at the 
interface
The main problem with identifying or quantifying the 
transmission of zoonotic tuberculosis at the human-animal 
interface is the failure to adopt appropriate diagnostic tools 
that can discriminate between M. bovis and M. tuberculosis, 
or other species of mycobacteria at routine diagnostic 
settings, particularly in low-income countries. This is not 
surprising, given the huge burden of disease, particularly of 
M. tuberculosis and the low per capita income of those 
countries. A further reason for this problem is that many 
clinicians show no interest in differentiating the causative 
agent, since initial treatment is the same. As a result the 
contribution of mycobacteria such as M. bovis to the global 
human TB burden is almost certainly underestimated. Despite 
these problem and long before such discriminatory tests 
became available, the test-and-slaughter scheme has proven 
to be an efficient control method for bovine tuberculosis in 
developed countries, although it is considered expensive 
(Michel et al. 2010) and is not yet accepted by all farmers 
(Bennett 2009; Torgerson & Torgerson 2009). Consequently, 
the joint impact of these important pathogens to national and 
global economies is still unknown. 
Different and inflexible policies guiding the practice of 
veterinary and medical practitioners are also potential 
barriers to what may be an immediate positive impact on 
zoonotic TB control strategies in most developing countries. 
The prevalence of human TB and livestock TB has been 
reported to correlate (Cosivi et al. 1998) despite contradicting 
reports on animal-human active transmission of zoonotic TB 
(Cousins, Williams & Dawson 1999; Dankner & Davis 2000; 
Dankner et al. 1993; Jalava et al. 2007; Romano et al. 1995, 1996; 
Zumarraga et al. 1999). The absence of genetic relatedness 
amongst M. bovis isolates leading to these controversies is in 
all likelihood simply a matter of incomplete sampling and 
reactivation disease (Mignard, Pichat & Carret 2006). This 
is supported by a report from Baker et al. (2006) who found 
many genotypes in human TB identical to patterns from 
farmed and wild animals. With the current advancement 
in molecular techniques for evaluation of infectious 
agents, exploiting these skills and using them for both 
epidemiological and evolutionary analysis of mycobacterial 
populations infecting humans and animals (Baker et al. 2004) 
and assessment of their cross-transmission amongst these 
species is possible and important.
Pathogen flow and disease dynamics of M. bovis has been 
broadly reported in South Africa’s wildlife and livestock 
(Michel 2002b; Michel et al. 2006, 2010) showing that the 
African buffalo is the major reservoir of infection in wildlife 
in that ecosystem. Thus, although originally a naïve host and 
infected by cross-over from cattle initially, the buffalo have 
become a source of infection for many other species, through 
dissemination of bacilli in the environment or predation 
(Keet et al. 1996; Michel 2002a, 2002b; Michel et al. 2004, 2006, 
2007, 2010). Although fairly the extensive studies have been 
done in the South African National Parks, little has been done 
in the large National Parks of Tanzania, such as Serengeti, 
Ruaha and Mikumi, where a large number of buffaloes are 
found. Unlike the South African parks, where there is little 
or no contact with domestic stock, in Tanzania infected 
buffalo could be reservoirs of bovine TB contributing to the 
increasing prevalence of tuberculosis in both humans and 
livestock, through mechanisms described below. 
Some legal and controlled hunting is allowed in open areas, 
Game Controlled Areas (GCAs) and game reserves for game-
meat in Tanzania but there is no established meat inspection 
to monitor TB or other infections in these game products. In 
addition, people around game reserves and national parks 
practice illegal or bush meat hunting and hidden sale of 
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game meat in villages and therefore difficult to control or 
conduct meat inspection. The situation is worsened during 
extensive droughts when food becomes scarce, resulting 
in increased poaching activities. In such circumstances, the 
contact between species at their interface and probability of 
infected meat entering the human food chain may increase 
with consequent spillover and cross-transmission of infection 
amongst populations (Osofsky et al. 2005). In addition, the 
life expectancy of livestock held by small scale farmers is 
generally higher than in commercial livestock keeping and 
bovine tuberculosis as a chronic and progressive disease 
manifests itself more often in older animals, under nutritional 
or productive stress (Michel et al. 2006). This socio-cultural 
behaviour when combined with close proximity with wildlife 
is detrimental to either ecosystem in terms of tuberculosis 
cross-transmission.
Molecular epidemiological 
– diagnostic tools and their 
application in developing countries
The development of molecular tools for identification of 
M. bovis, the known zoonotic TB causing mycobacterium, 
and differentiation from other members of the M. tuberculosis 
complex have allowed the discovery of more cases in 
retrospective studies and have suggested new forms of 
transmission (Cataldi & Romano 2007). In addition, the 
usefulness of molecular tools in normal practices of 
prevention and control of tuberculosis has been addressed 
(McNabb, Braden & Navin 2002). Genotyping of mycobacterial 
isolates in the mycobacterium tuberculosis complex has 
the ability to distinguish amongst clonal populations and 
provide key information on disease dynamics. However, 
this approach has been insufficiently applied in developing 
countries due to lack of facilities, resources and scarce skilled 
personnel. Molecular techniques such as PCR are powerful 
tools to identify mycobacteria and can potentially be used 
on cultured and original biological samples. Application of 
more than one molecular technique can complement each 
other in differentiating various strains or isolates and shed 
light on the phylogenetics and ultimately the transmission 
chains, thereby allowing for improved control or policy 
development (Michel et al. 2010).
Such actions require specific and dedicated support and 
government commitment for wide use and sustainability. 
Very few molecular epidemiological studies on tuberculosis 
have been done in Tanzania and even those few have been 
made possible mainly through collaborations. These studies 
have focused on the epidemiology of the disease in livestock 
or in wildlife, or have dealt with the disease in humans. As 
yet, tracking transmission across species using molecular 
tools such as RFLP (Michel 2002b) in Tanzania has been 
limited or almost non-existent. 
One Health as a Disease control 
strategy
Management of diseases in wildlife is complex because 
the current wildlife policy in Tanzania does not generally 
advocate treatment or vaccination to control infection and 
disease. Treatment or vaccination is only allowed if a disease 
outbreak occurs in endangered wildlife species or the 
outbreak poses a threat to the species population. Of course 
it must also be acknowledged that vaccination is not effective 
in all diseases, TB being one such example. Moreover, the 
logistics and funding required for treatment or vaccination 
in wildlife also make it largely impractical because it is 
almost impossible to get all animals, except perhaps very 
rare species (Osofsky et al. 2005). In most of Africa, small 
scale farmer’s livestock and their products are largely 
excluded from veterinary and veterinary public health 
control measures (Michel et al. 2004). Therefore, a change in 
policy and the political will that is necessary to support such 
recommendations will be necessary to reduce infection and 
disease. We need a two-pronged approach to address both 
technical and political issues to formulate a way forward. A 
policy that is focused on control of zoonotic TB and which 
addresses the need for a ‘One Health’ approach, through 
which veterinary and medical professions as well as social 
scientists and ecologists can work together to limit disease 
would be a new venture with a chance of success. 
Conclusions
Due to differences in national policies which guide different 
sectors of the Tanzanian economy (health, livestock and 
wildlife), the immediate suggested approach would be 
to prevent contact between wildlife and livestock and to 
control the disease (TB) in livestock through introduction 
of a compulsory test and slaughter practice, a proven recipe 
in other countries. This will reduce the transmission of 
disease not only between livestock and humans, but also 
limit transmission of infection from wildlife and vice versa. 
The implementation should include a policy that strictly 
prohibits livestock introgression to national parks and game 
reserves by implementing a boundary, beyond which animal 
keeping is unlawful. This however, has a problem in that 
even if livestock are kept out of this zone, wildlife will not 
understand that zone and will move into it, such that the 
‘zone’ will then move outwards to contact livestock again 
posing a big challenge on the strategy. The other remaining 
challenge is to convince policy makers and creating 
awareness in livestock keepers concerning the magnitude of 
the problem its consequences and the importance of disease 
control even impacts across international borders. The 
Serengeti National Park, for example, spans two countries 
and animal movement to the other side of the park into the 
Kenyan Maasai Mara might be contributing to an increased 
transmission risk not only to the wildlife in that country but 
also the livestock and humans in the neighbouring country. 
This is also applicable from Kenya to Tanzania, of course, as 
it would be for any transfrontier park. 
Although some work has been done we still do not have any 
accurate estimate of the extent of human-animal cross-species 
transmission in Tanzania, possibly elsewhere, with regard 
to TB. Much of this is because of the technical complexity 
and cost of cultures and speciation. In addition, additional 
Proceeding
doi:10.4102/ojvr.v79i2.501http://www.ojvr.org
Page 5 of 6
problems include bias in previous studies owing to sampling 
from urban areas and pulmonary samples as well as challenge 
of detecting infection rather than disease and attributing 
it to transmission, together with the assumption that it is a 
particular species of mycobacterium. Studies are currently 
underway in and around the Serengeti National Park under 
the umbrella of the Southern Centre for Infectious Disease 
Surveillance (SACIDS), to try to establish the clear trans-
boundary interaction between human-livestock-wildlife 
and TB transmission. Once one has a clear understanding of 
these factors, it may be possible to suggest an appropriate 
‘One Health’ approach to arrest pathogen flow and interrupt 
prevailing disease dynamics across species. In our opinion, 
research aiming to identify and characterise pathogens (not 
only mycobacterial species) of animals with potential to be 
infective to humans (Wolfe et al. 2007) should be prioritised 
in order to enable us know the potential source of diseases to 
become proactive and hopefully prevent or limit outbreaks. 
To successfully implement this strategy, a sustainable 
and efficient collaborative approach involving multiple 
stakeholders from various sectors and working groups 
is needed. 
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